Giuseppe DeIuliis
Research Assistant Internal Medicine PulmonaryAbout
Research
Publications
2024
Nebulizable Conjugates to Sustain Retention, Delivery, and Efficacy of Galectin-3 Inhibitory Drug TD139 in the Alveolar Space
Marti Munoz J, Khoury J, Ahangari F, Deiuliis G, Kaminski N, Pandit A. Nebulizable Conjugates to Sustain Retention, Delivery, and Efficacy of Galectin-3 Inhibitory Drug TD139 in the Alveolar Space. 2024, a3218-a3218. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a3218.Peer-Reviewed Original ResearchIPF Aberrant Basaloid Cells Have Chromatin Accessibility Features Distinct From Other Lung Epithelial Cells
Adams T, Schupp J, Balayev A, Justet A, Sharma P, Anderson S, Nekola F, Deiuliis G, Yan X, Wuyts W, Vanaudenaerde B, Kaminski N. IPF Aberrant Basaloid Cells Have Chromatin Accessibility Features Distinct From Other Lung Epithelial Cells. 2024, a4898-a4898. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4898.Peer-Reviewed Original Research
2016
P056 Loss of MAP Kinase Phosphatase 5 (MKP5) attenuates fibrotic responses in-vitro and in-vivo
Tzouvelekis A, Xylourgidis N, Kisuk M, Yu G, Herazo-maya J, Aurelien N, Adams T, Woolard T, Ibarra G, Deiuliis G, Binzenhöfer L, Bennett A, Kaminski N. P056 Loss of MAP Kinase Phosphatase 5 (MKP5) attenuates fibrotic responses in-vitro and in-vivo. QJM 2016, 109: s40-s40. DOI: 10.1093/qjmed/hcw124.028.Peer-Reviewed Original Research